Showing results (171-180 of 277) with videos related to
Sort By:
Pageof 28
JAMA Oncology|October 20, 2022
Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer: A Narrative ReviewMatthew G Krebs, Umberto Malapelle, Fabrice André, et al.Clinical Sarcoma Research|August 1, 2013
The attitudes of people with sarcoma and their family towards genomics and incidental information arising from genetic researchMary-Anne Young, Amy Herlihy, Gillian Mitchell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2012
Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of boneDaniel G Branstetter, Scott D Nelson, J Carlos Manivel, et al.Neurotoxicology|July 6, 2010
Soman increases neuronal COX-2 levels: possible link between seizures and protracted neuronal damageMariana Angoa-Pérez, Christian W Kreipke, David M Thomas, et al.Plos One|October 11, 2012
qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profilesSarah Song, Katia Nones, David Miller, et al.Proceedings of the National Academy of Sciences of the United States of America|November 21, 2008
Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1-/- miceGabriel M Gutierrez, Elizabeth Kong, Yves Sabbagh, et al.Nature Communications|February 25, 2017
IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoeditingKazuyoshi Takeda, Masafumi Nakayama, Yoshihiro Hayakawa, et al.Nature Communications|March 5, 2024
Topological barrier to Cas12a activation by circular DNA nanostructures facilitates autocatalysis and transforms DNA/RNA sensingFei Deng, Yi Li, Biyao Yang, et al.EMBO Molecular Medicine|June 17, 2015
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacyBryan W Miller, Jennifer P Morton, Mark Pinese, et al.Cancer|October 15, 2014
Clinical and pathologic features of familial pancreatic cancerJeremy L Humphris, Amber L Johns, Skye H Simpson, et al.Pageof 28